5-(3,5-difluorophenyl)-3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole

ID: ALA507182

PubChem CID: 12002518

Max Phase: Preclinical

Molecular Formula: C13H10F2N6

Molecular Weight: 288.26

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Fc1cc(F)cc(C2Cc3[nH]nc(-c4nnn[nH]4)c3C2)c1

Standard InChI:  InChI=1S/C13H10F2N6/c14-8-1-6(2-9(15)5-8)7-3-10-11(4-7)16-17-12(10)13-18-20-21-19-13/h1-2,5,7H,3-4H2,(H,16,17)(H,18,19,20,21)

Standard InChI Key:  LUAGNVOTAGSBDC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 24  0  0  0  0  0  0  0  0999 V2000
   21.6003  -21.7509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0703  -22.4290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1000  -21.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8789  -21.3666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8596  -22.1887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6355  -22.4609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1342  -21.8072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6665  -21.1310    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8721  -23.2513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3717  -23.9059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8408  -24.5845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.6313  -24.3480    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.6505  -23.5231    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7755  -21.7325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3842  -21.0071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5601  -20.9884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1310  -21.6941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5319  -22.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3546  -22.4352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1060  -23.1267    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.1640  -20.2647    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  5  1  0
  4  3  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
  3  1  1  0
  1 14  1  0
  5  6  1  0
 14 15  2  0
  6  7  2  0
 15 16  1  0
  7  8  1  0
 16 17  2  0
  8  4  1  0
 17 18  1  0
  4  5  2  0
 18 19  2  0
 19 14  1  0
  6  9  1  0
 18 20  1  0
  9 10  1  0
 16 21  1  0
M  END

Associated Targets(Human)

HCAR2 Tclin Hydroxycarboxylic acid receptor 2 (1903 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hcar2 Hydroxycarboxylic acid receptor 2 (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 288.26Molecular Weight (Monoisotopic): 288.0935AlogP: 1.75#Rotatable Bonds: 2
Polar Surface Area: 83.14Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.38CX Basic pKa: 1.27CX LogP: 2.42CX LogD: 0.81
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.75Np Likeness Score: -1.48

References

1. Imbriglio JE, Chang S, Liang R, Raghavan S, Schmidt D, Smenton A, Tria S, Schrader TO, Jung JK, Esser C, Taggart AK, Cheng K, Carballo-Jane E, Gerard Waters M, Tata JR, Colletti SL..  (2009)  GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.,  19  (8): [PMID:19307116] [10.1016/j.bmcl.2009.03.014]

Source